HealthAugust 4, 2026
azetukalner
uh-ZET-uh-kal-ner
Definition
An investigational pharmaceutical agent currently being studied as a potassium channel opener for the treatment of focal onset seizures in epilepsy.
Etymology
This is a coined, proprietary drug name derived from modern pharmaceutical naming conventions, intended to sound distinct and professional in clinical research contexts.
In the news
Azetukalner is mentioned as a new, specific therapy in the drug development pipeline that, if approved, would provide a novel mechanism of action for epilepsy patients.
Epilepsy Market Growth Outlook 2036: Epidemiology, Pipeline Therapies, and Revenue Forecast - DelveInsight
Read the full article ↗openPR.com